vs
Business First Bancshares, Inc.（BFST）与Vericel Corp（VCEL）财务数据对比。点击上方公司名可切换其他公司
Vericel Corp的季度营收约是Business First Bancshares, Inc.的1.1倍（$92.9M vs $83.1M），Vericel Corp同比增速更快（23.3% vs 7.1%），Business First Bancshares, Inc.自由现金流更多（$92.0M vs $12.8M），过去两年Vericel Corp的营收复合增速更高（34.6% vs 16.8%）
第一公民银行股份公司是一家银行控股公司，总部位于美国北卡罗来纳州罗利，是美国规模最大的银行机构之一。公司核心子公司第一公民银行在全美23个州经营着超过500家网点，另一子公司硅谷银行则在15个州设有39家办事处。
Vericel Corp是一家美国上市生物制药企业，前身为1989年在密歇根州安娜堡成立的Aastrom Bio，2014年10月正式更为现名，专注于生物制药相关领域的研发与商业化运营。
BFST vs VCEL — 直观对比
营收规模更大
VCEL
是对方的1.1倍
$83.1M
营收增速更快
VCEL
高出16.2%
7.1%
自由现金流更多
BFST
多$79.2M
$12.8M
两年增速更快
VCEL
近两年复合增速
16.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $83.1M | $92.9M |
| 净利润 | — | $23.2M |
| 毛利率 | — | 78.7% |
| 营业利润率 | 33.2% | 24.1% |
| 净利率 | — | 25.0% |
| 营收同比 | 7.1% | 23.3% |
| 净利润同比 | — | 17.3% |
| 每股收益（稀释后） | $0.71 | $0.46 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BFSTVCEL
| Q4 25 | $83.1M | $92.9M | ||
| Q3 25 | $80.9M | $67.5M | ||
| Q2 25 | $81.5M | $63.2M | ||
| Q1 25 | $79.2M | $52.6M | ||
| Q4 24 | $77.6M | $75.4M | ||
| Q3 24 | $66.9M | $57.9M | ||
| Q2 24 | $66.2M | $52.7M | ||
| Q1 24 | $60.9M | $51.3M |
净利润BFSTVCEL
| Q4 25 | — | $23.2M | ||
| Q3 25 | $22.9M | $5.1M | ||
| Q2 25 | $22.1M | $-553.0K | ||
| Q1 25 | $20.5M | $-11.2M | ||
| Q4 24 | — | $19.8M | ||
| Q3 24 | $17.8M | $-901.0K | ||
| Q2 24 | $17.2M | $-4.7M | ||
| Q1 24 | $13.6M | $-3.9M |
毛利率BFSTVCEL
| Q4 25 | — | 78.7% | ||
| Q3 25 | — | 73.5% | ||
| Q2 25 | — | 73.7% | ||
| Q1 25 | — | 69.0% | ||
| Q4 24 | — | 77.6% | ||
| Q3 24 | — | 71.9% | ||
| Q2 24 | — | 69.5% | ||
| Q1 24 | — | 68.9% |
营业利润率BFSTVCEL
| Q4 25 | 33.2% | 24.1% | ||
| Q3 25 | 35.7% | 5.1% | ||
| Q2 25 | 34.4% | -3.2% | ||
| Q1 25 | 32.6% | -24.3% | ||
| Q4 24 | 27.5% | 24.5% | ||
| Q3 24 | 34.0% | -4.3% | ||
| Q2 24 | 32.9% | -11.5% | ||
| Q1 24 | 28.2% | -10.7% |
净利率BFSTVCEL
| Q4 25 | — | 25.0% | ||
| Q3 25 | 28.2% | 7.5% | ||
| Q2 25 | 27.1% | -0.9% | ||
| Q1 25 | 25.9% | -21.4% | ||
| Q4 24 | — | 26.3% | ||
| Q3 24 | 26.7% | -1.6% | ||
| Q2 24 | 26.0% | -8.9% | ||
| Q1 24 | 22.3% | -7.5% |
每股收益（稀释后）BFSTVCEL
| Q4 25 | $0.71 | $0.46 | ||
| Q3 25 | $0.73 | $0.10 | ||
| Q2 25 | $0.70 | $-0.01 | ||
| Q1 25 | $0.65 | $-0.23 | ||
| Q4 24 | $0.51 | $0.40 | ||
| Q3 24 | $0.65 | $-0.02 | ||
| Q2 24 | $0.62 | $-0.10 | ||
| Q1 24 | $0.48 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $411.2M | $137.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $896.9M | $354.6M |
| 总资产 | $8.2B | $488.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BFSTVCEL
| Q4 25 | $411.2M | $137.5M | ||
| Q3 25 | $399.1M | $135.4M | ||
| Q2 25 | $495.8M | $116.9M | ||
| Q1 25 | $312.9M | $112.9M | ||
| Q4 24 | $319.1M | $116.2M | ||
| Q3 24 | $213.2M | $101.7M | ||
| Q2 24 | $208.1M | $102.5M | ||
| Q1 24 | $185.9M | $110.6M |
股东权益BFSTVCEL
| Q4 25 | $896.9M | $354.6M | ||
| Q3 25 | $878.4M | $321.9M | ||
| Q2 25 | $848.4M | $306.8M | ||
| Q1 25 | $826.3M | $295.5M | ||
| Q4 24 | $799.5M | $292.0M | ||
| Q3 24 | $699.5M | $257.5M | ||
| Q2 24 | $664.5M | $243.0M | ||
| Q1 24 | $649.0M | $233.9M |
总资产BFSTVCEL
| Q4 25 | $8.2B | $488.0M | ||
| Q3 25 | $8.0B | $453.3M | ||
| Q2 25 | $7.9B | $435.6M | ||
| Q1 25 | $7.8B | $424.6M | ||
| Q4 24 | $7.9B | $432.7M | ||
| Q3 24 | $6.9B | $390.4M | ||
| Q2 24 | $6.7B | $376.8M | ||
| Q1 24 | $6.7B | $356.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $92.1M | $15.0M |
| 自由现金流经营现金流 - 资本支出 | $92.0M | $12.8M |
| 自由现金流率自由现金流/营收 | 110.7% | 13.8% |
| 资本支出强度资本支出/营收 | 0.1% | 2.4% |
| 现金转化率经营现金流/净利润 | — | 0.65× |
| 过去12个月自由现金流最近4个季度 | $165.6M | $24.7M |
8季度趋势，按日历期对齐
经营现金流BFSTVCEL
| Q4 25 | $92.1M | $15.0M | ||
| Q3 25 | $32.4M | $22.1M | ||
| Q2 25 | $14.0M | $8.2M | ||
| Q1 25 | $28.7M | $6.6M | ||
| Q4 24 | $61.4M | $22.2M | ||
| Q3 24 | $21.4M | $10.2M | ||
| Q2 24 | $15.1M | $18.5M | ||
| Q1 24 | $7.6M | $7.2M |
自由现金流BFSTVCEL
| Q4 25 | $92.0M | $12.8M | ||
| Q3 25 | $32.1M | $19.5M | ||
| Q2 25 | $13.8M | $81.0K | ||
| Q1 25 | $27.7M | $-7.6M | ||
| Q4 24 | $59.8M | $8.5M | ||
| Q3 24 | $21.0M | $-9.2M | ||
| Q2 24 | $14.0M | $1.8M | ||
| Q1 24 | $7.2M | $-6.8M |
自由现金流率BFSTVCEL
| Q4 25 | 110.7% | 13.8% | ||
| Q3 25 | 39.6% | 28.8% | ||
| Q2 25 | 16.9% | 0.1% | ||
| Q1 25 | 34.9% | -14.5% | ||
| Q4 24 | 77.1% | 11.2% | ||
| Q3 24 | 31.4% | -15.9% | ||
| Q2 24 | 21.2% | 3.4% | ||
| Q1 24 | 11.8% | -13.3% |
资本支出强度BFSTVCEL
| Q4 25 | 0.1% | 2.4% | ||
| Q3 25 | 0.4% | 3.9% | ||
| Q2 25 | 0.3% | 12.9% | ||
| Q1 25 | 1.3% | 27.0% | ||
| Q4 24 | 2.0% | 18.3% | ||
| Q3 24 | 0.6% | 33.5% | ||
| Q2 24 | 1.6% | 31.8% | ||
| Q1 24 | 0.6% | 27.3% |
现金转化率BFSTVCEL
| Q4 25 | — | 0.65× | ||
| Q3 25 | 1.42× | 4.35× | ||
| Q2 25 | 0.63× | — | ||
| Q1 25 | 1.40× | — | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | 1.20× | — | ||
| Q2 24 | 0.88× | — | ||
| Q1 24 | 0.56× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BFST
暂无分部数据
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
